Jean-Marc Bellemin
Chief Financial Officer, Gritstone bio, Inc.
Companies
- Iovance BiotherapeuticsChief financial officer Dec 17, 2020 to Aug 8, 20251
- Gritstone bio, Inc.Officer Mar 14, 2019 to Feb 27, 20202
- Gritstone bio, Inc.Chief financial officer Sep 27, 2018 to Sep 27, 20183
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Iovance Biotherapeutics IOVA60,529 shares4$842.6K at $13.92Jun 2, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 2, 2025Shares withheld for tax 4,464 shares at $1.76 of Iovance Biotherapeutics4
- Jun 2, 2025Exercised options 8,789 shares of Iovance Biotherapeutics4
- Mar 3, 2025Shares withheld for tax 31,734 shares at $4.04 of Iovance Biotherapeutics5
- Mar 3, 2025Exercised options 58,590 shares of Iovance Biotherapeutics5
- Sep 3, 2024Shares withheld for tax 11,891 shares at $10.85 of Iovance Biotherapeutics6
- Sep 3, 2024Exercised options 23,438 shares of Iovance Biotherapeutics6
- Jan 3, 2023Shares withheld for tax 10,553 shares at $6.11 of Iovance Biotherapeutics7
- Jan 3, 2023Exercised options 18,850 shares of Iovance Biotherapeutics7
- Jun 14, 2022Shares withheld for tax 9,346 shares at $7.73 of Iovance Biotherapeutics8
- Jun 14, 2022Exercised options 18,850 shares of Iovance Biotherapeutics8
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARGritstone bio, Inc., Officer
- 3
- 4
- 5SEC EDGARForm 4 filed Mar 5, 2025
- 6SEC EDGARForm 4 filed Sep 5, 2024
- 7SEC EDGARForm 4 filed Jan 5, 2023
- 8SEC EDGARForm 4 filed Jun 16, 2022